Director Shareholding

GlaxoSmithKline PLC
10 January 2003


                              Director's Interests

I give below details of changes in interests in the Ordinary Share ADRs of
GlaxoSmithKline plc (each ADR represents two Ordinary Shares) in respect of the
under-mentioned Directors arising from the reinvestment of the dividend paid to
Ordinary Share ADR holders on 3 January 2003 through the US Global BuyDirect
Plan administered by The Bank of New York:


Mr D F McHenry                      Beneficial interest in 0.2554 of an Ordinary
                                    Share ADR purchased at a price of $39.0290
                                    per ADR.

Mr J H McArthur                     Beneficial interest in 33.5474 Ordinary 
                                    Share ADRs purchased at a price
                                    of US$ 39.0290 per ADR.


                                The Directors and the Company were advised of
                                this information on 9 January 2003.

S M Bicknell

Company Secretary

10 January 2003




                      This information is provided by RNS
            The company news service from the London Stock Exchange